Pilot Trial: Comparing Buzzy to Intradermal Lidocaine for Peripheral IV Cannulation in Adults

NCT04647084 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The investigators were unable to begin work on this study.

Conditions

Pain, Acute
Patient Satisfaction

Interventions

DRUG: Lidocaine 2% Injectable Solution
DEVICE: Buzzy

Sponsor

Steward St. Elizabeth's Medical Center of Boston, Inc.